Tigermed Closes Series A Financing

Tigermed Consulting announced that it has closed its Series A financing from Qiming Venture Partners, a venture capital firm based in Shanghai. With capital injection, Tigermed said it has entered into a period of rapid expansion. Tigermed is one of the largest Contract Research Organizations (CRO) in China, having played a leading role in the country's clinical trials industry. "Over the past six years, we have established a globally competitive team with more than 100 professionals. We have set up 13 offices in both the U.S. and China, with 150 business customers from both home and abroad. Our leading management and service system and our world class data management system have laid a solid foundation for the rapid development of Tigermed," Dr. Ye Xiaoping, CEO and founder of Tigermed. "In the past, we turned down quite a... [read full story]